Boston Children’s Hospital Takes Stake in For-Profit Genomics Company

Boston Children’s Hospital and biotechnology firm Life Technologies have launched Claritas Genomics, a for-profit joint venture that will look to develop new genomics-based healthcare solutions.

Advertisement

Boston Children’s, a non-profit, 395-bed teaching affiliate of Harvard Medical School, will be the majority owner. In a statement, hospital President and CEO Sandra Fenwick said the new company also aims to “advance the standard of care” through genomic sequencing and molecular diagnostics and extend the experiment to others around the country and world.

Investor-owned Life Technologies recorded sales of $3.7 billion in 2011.

More Articles on Non-Profit Hospital Finances:

5 Areas Where Hospitals Can Spend Smarter
4 Drivers of Healthcare Capital Financing — And How They Affect CFOs
UMass Memorial Medical Center Sells Lab Businesses

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.